conference Programme

This is the latest programme, which will be updated during the following weeks.

Tuesday, November 7th 2023




Griya Agung Ballroom

08.00 - 08.30


08.30– 09.15


Opening Ceremony

Mira Harrison Woolrych - Chair of the Scientific Committee

Functionary - Head of National Drug and Food Agency (BPOM) Indonesia (Virtual)

09.15 -10.45


Plenary Session: Protecting Patients From Harm

Chairpersons: Mira Harrison Woolrych and

Jarir At Thobari

09.15 - 09.20

Introduction by Chairs

09.20 - 09.55

Protecting Patients from The Harms of Pharmaceutical Products:
How can International Pharmacovigilance Perform Better?

09.55 - 10.25

Monitoring the Safety of Medicines in Pregnancy: The Hong Kong Experience

10.25 - 10.45

Questions & Discussion

10.45 - 11.15

Break and Poster Viewing


Plenary session: Patient Engagement in Pharmacovigilance

11.15 -11.20

Introduction by Chairs

11.20 - 11.45

Patient Involvement in Patient Safety Across The World

Michael Ramsay (virtual presentation)

11.45 - 12.10

CIOMS WG XI Report; Patient Involvement in The Development, Regulation and Safe Use of Medicines

12.10 – 12.30

Patient Experience

Susannah Latham (virtual presentation)

12.30 – 12.35

Panel Discussion: Taking a Regional Approach in Patient Engagement and Safety Decision Making.

12.35 – 12.45

Q&A with Audience

12.45 - 14.00


12.45 - 14.00

Meet-the-Editor-Session (Kintamani Room)

Nitin Joshi (Editor-in-Chief of The Drug Safety Journal)

ROOM 1 - Griya Agung Ballroom

ROOM 2 - Denpasar Room

14.00 - 15.30


Parallel Session 1C: Hot Topics in SE Asia and Western Pacific Region

Jarir At Thobari


Parallel Session 1D: Ecopharmacovigilance

Chairpersons: Joan D’Souza and

14.00 -14.20

Pharmacovigilance in Medical Tourism

Ady Wirawan

14.20 - 14.30

Ecopharmacovigilance: Current Regulations and Required Strategies for Environmental Safety

14.30 - 14.40

Update Risk Minimization Practices in Indonesia

Nova Emelda

14.40 - 15.00

Incorporating ASEAN Patient’s Perspective in Benefit vs Risk Evaluation.

Juhaeri Juhaeri

Role of Pharmacovigilance Experts in EcoPV

15.00 - 15.10

Oral Presentation from Abstract (ISOP23-O01) - New Zealand Experience of Empagliflozin - High Reporting Rate of Fournier’s Gangrene/Necrotising Fasciitis

Oral Presentation from Abstract (ISOP23-O03) - Critical Review of Environmental Impact of Desflurane

Joseph Mitchel (Presented by Jerin Jose Cherian)

15.10 - 15.20

Oral Presentation from abstract (ISOP23-O02) - A Comparative Study of The Effectiveness of Large Language Models in Identifying Adverse Drug Reactions from Discharge Summaries in Singapore.

Oral Presentation from Abstract (ISOP23-O04) - The Community Pharmacy as a Focal Point for Ecopharmacovigilance Practices – a look at Krowor Municipality, Ghana

Y Yirenkyiwaa Esseku

15.20 -15.30

Q&A with Audience

15.30 -16.00

Break and Poster Viewing

ROOM 1 - Griya Agung Ballroom

ROOM 2 - Denpasar Room

16.00 - 17.30


Parallel Session 1E: Drug Safety in Older Patients

Jo Hikaka


Parallel Session 1F: Methods in Vaccine Pharmacovigilance

Chairpersons: Agnes Kant and

Jarir At thobari

16.00 -16.15

Optimizing Safety Surveillance for COVID-19 Vaccines at the National Pharmacovigilance Centre Lareb

16.15 -16.30

Phamacovigilance and The Multi-Morbid Elderly Patient: How do We Support Patient Safety?

Vaccine safety in Australia During the COVID-19 Pandemic: Lessons Learned on The Frontline

16.30 - 16.45

Vaccine Safety in Indonesia

Hindrawan Satari

16.45 - 17.00

Improving Safety of Medicines in Older Māori

"Assessing Vaccine Safety at the Global Level: Introduction to the Global Vaccine Data Network (GVDN)"

17.00 - 17.10

Oral Presentation from Abstract (ISOP23-O06) - Trends in Dual Antiplatelet Therapy (DAPT) Prescription for Elderly Patients with Acute Coronary Syndrome (ACS): A 5-year Pharmacoepidemiological Study Using the National Cardiovascular Disease (NCVD).

Oral Presentation from Abstract (ISOP23-O07) - Thyroid Status, Timing of Vaccine and Sex as Determinants of Persistent Health Issues after COVID-19 Vaccines

Upinder Kaur

17.10- 17.20

Oral Presentation from Abstract (ISOP23-O05) - Balance Disorder as a Potential Cause of Fall in Patients Taking Enzalutamide

Oral Presentation from Abstract (ISOP23-O08) - Preliminary Evaluation of Safety Profile of Pfizer BioNTech COVID-19 Vaccine Use Among Pregnant Women in Ghana; a Cohort Event Monitoring Study

17.20 - 17.30

Question & Answer

17.30 - 18.30

SIG Meeting : Pharmacogenomics (Kintamani Room)

SIG Meeting : Real-World Evidence and Big Data (Denpasar Room)

End of Conference Day 1